Novartis AG vs Stitch Fix Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Stitch Fix Inc trades at $3.94 (market cap $520.36M). The key difference: Novartis AG is far larger — about 557.8× Stitch Fix Inc's market cap, and Novartis AG pays a 3.17% dividend while Stitch Fix Inc pays none. Which is the better fit depends on your goals.
| NVS | SFIX | |
|---|---|---|
Market Cap | $290.25B | $520.36M |
Sector | Health | Consumer Cyclical |
52-Week High | $168.62 | $5.83 |
52-Week Low | $113.50 | $3.06 |
Enterprise Value | $330.27B | $408.08M |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →